IREDA board approves raising Rs 5000 crore via QIP

Key renewable power play IREDA board has approved raising Rs 5000 crore through a QIP or qualified institutions placement in one or more tranches. The filing at the exchanges specified that the board has decided that fund raising is subject to shareholder approval and Govt shareholding will not decirease more than 7% of the company’s post-issue paid-up equity share capital.

The funds raised are expected to be used to support demand for green energy financing. It will be put to use to scale up support for clean energy financing initiatives in the country.

IREDA raised Rs 4500 cr via QIP in September, 2024

This is second approval from the Indian Renewable Energy Development Agency board for raising funds via QIP in a span of less than 6 months. The board had earlier approved raising up to Rs 4,500 crore through another QIP in September last yea. DIPAM (The Department of Investment and Public Asset Management) approved this fresh equity issue.

Why did IREDA chose to raise funds via QIP

QIP or qualified institutions placement is an instrument to raise funds. Companies use it to raise funds via qualified institutional buyers. Some of the key advantages of this kind of fund raising initiative include lower transaction costs,  better pricing, and access to exclusive deals. However, it is dependent on market rates and runs the risk of underpricing depending on market conditions.

IREDA stock Vs Nifty

The IREDA stock ended Thusday’s session down 2%. It had slumped to intrad-day low of Rs 195.29, down 3% before recovering some ground in late trade. The stock hit a 52-week low of Rs 121 on March, 2024 while it hits its 52-week high on July last year. The stock is down over 5% in 5 days and a whopping 24% in last 6 months. However, over 1 year time-frame it has delivered 27% plus returns to investors.

In the same period if we compare the stock to Nifty’s performance, Nifty gave investors 9% returns over 1 year while over 6 months, the benchmark Index deliveed negative returns of 5%.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth